Unknown

Dataset Information

0

Genotype frequencies for polymorphisms related to chemotherapy-induced nausea and vomiting in a Japanese population.


ABSTRACT: BACKGROUND:Genotype frequencies for chemotherapy-induced nausea and vomiting (CINV)-related polymorphisms have not yet been reported for Japanese subjects. METHODS:We analyzed 10 genotype frequencies for following polymorphisms associated with the development of CINV: serotonin 5-HT3 receptors (HTR3); neurokinin-1 receptors (Tachykinin-1 receptors, TACR1); dopamine D2 receptors (DRD2); and catechol-O-methyltransferase (COMT). RESULTS:All polymorphisms were successfully genotyped in 200 Japanese subjects and were in Hardy-Weinberg equilibrium. Almost all genotype frequencies were similar to those in the HapMap database or in the previous reports, while frequencies for the Y192H polymorphism in TACR1 were different in Japanese subjects from those in a previous report. CONCLUSIONS:The present study revealed genotype frequencies for polymorphisms, which were related to the appearance of CINV in Japanese subjects. Individual therapy based on genotype variations for each race is needed to allow cancer patients to undergo chemotherapy more safely and to understand etiology of CINV.

SUBMITTER: Goto A 

PROVIDER: S-EPMC4955237 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

altmetric image

Publications

Genotype frequencies for polymorphisms related to chemotherapy-induced nausea and vomiting in a Japanese population.

Goto Aya A   Kotani Haruka H   Miyazaki Masayuki M   Yamada Kiyofumi K   Ishikawa Kazuhiro K   Shimoyama Yasuhiko Y   Niwa Toshimitsu T   Hasegawa Yoshinori Y   Noda Yukihiro Y  

Journal of pharmaceutical health care and sciences 20160721


<h4>Background</h4>Genotype frequencies for chemotherapy-induced nausea and vomiting (CINV)-related polymorphisms have not yet been reported for Japanese subjects.<h4>Methods</h4>We analyzed 10 genotype frequencies for following polymorphisms associated with the development of CINV: serotonin 5-HT3 receptors (HTR3); neurokinin-1 receptors (Tachykinin-1 receptors, TACR1); dopamine D2 receptors (DRD2); and catechol-O-methyltransferase (COMT).<h4>Results</h4>All polymorphisms were successfully geno  ...[more]

Similar Datasets

| S-EPMC7138899 | biostudies-literature
| S-EPMC8463343 | biostudies-literature
| S-EPMC5344450 | biostudies-literature
| S-EPMC4869612 | biostudies-other
| S-EPMC3938333 | biostudies-literature
| S-EPMC5524586 | biostudies-literature
| S-EPMC5386623 | biostudies-literature